SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 234.17 |
| Enterprise Value ($M) | 221.13 |
| Book Value ($M) | 49.39 |
| Book Value / Share | 0.74 |
| Price / Book | 4.74 |
| NCAV ($M) | 45.83 |
| NCAV / Share | 0.69 |
| Price / NCAV | 5.11 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.84 |
| Return on Assets (ROA) | -0.53 |
| Return on Equity (ROE) | -0.62 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.74 |
| Current Ratio | 4.74 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 59.33 |
| Assets | 62.90 |
| Liabilities | 13.50 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | BlackRock, Inc. | 5.90 | 0.00 | |
| 13G/A | Acorn Bioventures, L.p. | 4.20 | -36.03 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 204,663 | 1,156,881 | 17.69 | |
| 221,465 | 936,523 | 23.65 | |
| 352,172 | 1,241,154 | 28.37 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| COYA – Coya Therapeutics, Inc. | CPRX – Catalyst Pharmaceuticals, Inc. |
| CRBP – Corbus Pharmaceuticals Holdings, Inc. | CRIS – Curis, Inc. |
| CRVO – CervoMed Inc. |
Financial data and stock pages provided by
Fintel.io